Glatopa Injection, Solution
Product Images NDC 0781-3250

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Glatopa (NDC 0781-3250). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure_01 (Glatopa Image 01)

A Kaplan-Meier curve graph illustrating the percentage of patients experiencing a second exacerbation over time (days) comparing Glatiramer Acetate Injection 20 mg to placebo. The y-axis shows second exacerbation percentage, and the x-axis shows days up to 1080. The graph includes patient counts at various time points and statistical values (p=0.0005, Hazard Ratio=0.55).*

FDA Label Image

Figure_02 (Glatopa Image 02)

A line graph comparing the cumulative median number of enhancing lesions over 9 months between Glatiramer Acetate Injection and placebo groups. The x-axis represents months, and the y-axis shows the cumulative number of enhancing lesions. Two lines illustrate that Glatiramer Acetate Injection has a lower number of lesions than placebo over time.*

FDA Label Image

Figure_a (Glatopa Image 03)

An instructional illustration showing components of a subcutaneous injection kit. Included are a sharps disposal container with a biohazard symbol, cotton balls, alcohol wipes, a syringe in a blister package, and an injection diary. The items are labeled to indicate their purpose in the injection process.*

FDA Label Image

Figure_a (Glatopa Image 04)

An instructional illustration showing a pair of hands holding a syringe, with one hand stabilizing the syringe body and the other hand preparing the syringe cap or needle, representing part of the injection preparation process for a subcutaneous injection.*

FDA Label Image

Figure_c_abdomen (Glatopa Image 05)

An anatomical illustration showing a human torso from front view, highlighting the abdominal area with a circle, indicating a possible injection site for subcutaneous administration.*

FDA Label Image

Figure_c_hips_and_arms (Glatopa Image 06)

An anatomical illustration showing the back view of a human torso and upper legs, highlighting the upper arms with shaded areas to indicate the sites for subcutaneous injection, relevant for administration of Glatopa (Glatiramer Acetate) injection solution.*

FDA Label Image

Figure_c_arms (Glatopa Image 07)

An instructional diagram showing the proper subcutaneous injection site on the upper arm. The illustration depicts a person with a shaded area on the outer upper arm, indicating where to administer the injection of Glatopa (glatiramer acetate) solution.*

FDA Label Image

Figure_c_thighs (Glatopa Image 08)

Illustration showing the recommended injection sites for subcutaneous administration in the front thigh areas. The image highlights both upper outer thighs, indicating the proper locations for Glatopa (glatiramer acetate) injection.*

FDA Label Image

Figure_d (Glatopa Image 09)

An instructional illustration depicting the proper technique for subcutaneous injection of Glatopa (glatiramer acetate) solution. The image shows a hand pinching the skin on the upper arm, preparing for the injection.*

FDA Label Image

Figure_e (Glatopa Image 10)

Three-panel instructional illustration showing a hand holding a pen-like device. The sequence likely depicts steps in preparing or administering an injection, with each panel focusing on different hand positions and interaction with the device, consistent with subcutaneous injection use.*

FDA Label Image

Figure_f (Glatopa Image 11)

An instructional diagram showing a close-up of a hand holding an injection site on the skin, demonstrating the preparation or administration technique for a subcutaneous injection.*

FDA Label Image

Figure_g (Glatopa Image 12)

An instructional illustration showing a hand administering a subcutaneous injection into the skin of the abdomen using a syringe or injection device. The image focuses on proper injection technique for subcutaneous drug delivery.*

FDA Label Image

Figure_h (Glatopa Image 13)

An instructional line drawing showing a person administering a subcutaneous injection into the thigh area. The illustration depicts one hand holding a syringe while the other hand pinches the skin to prepare the injection site. The image is related to subcutaneous injection technique.*

FDA Label Image

Figure_i (Glatopa Image 14)

An instructional illustration showing a hand holding a syringe and inserting the needle into a site on another person's arm, demonstrating subcutaneous injection technique likely related to Glatopa (Glatiramer Acetate) injection administration.*

FDA Label Image

Figure_j (Glatopa Image 15)

An illustration showing a hand inserting a needle subcutaneously in the skin fold near the upper arm, demonstrating the proper injection technique for a subcutaneous injectable solution.*

FDA Label Image

Figure_k (Glatopa Image 16)

An instructional illustration showing a person administering a subcutaneous injection into the tissue of the abdomen or thigh using a syringe. The image highlights proper injection technique for a medication such as Glatopa (glatiramer acetate) injection solution.*

FDA Label Image

Figure_l (Glatopa Image 17)

An illustration showing a medical sharps disposal container with a biohazard symbol on the front. The container is designed for safe disposal of needles and other sharp medical waste.*

FDA Label Image

Glatopa_20_mg_carton (Glatopa Image 18)

Glatopa 20 mg/mL (glatiramer acetate injection) solution for subcutaneous injection by Sandoz Inc. The carton contains 30 single-dose pre-filled syringes. The label includes storage instructions (2 to 8°C), product usage indications, and dosage form details.*

FDA Label Image

Glatopa_40_mg _carton (Glatopa Image 19)

The packaging label for Glatopa (glatiramer acetate injection) 40 mg/mL solution, intended for subcutaneous injection. The label indicates it is to be taken three times a week and contains 12 single-dose pre-filled syringes. The manufacturer is Sandoz Inc. Storage instructions and ingredient details are visible on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.